Symposium Lipids and Lipidomics in Health and Disease


IGBMC, Strasbourg-Illkirch, December 2nd, 2015

Site internet:

Lipid metabolites are ranking in unique position in mediating specific cell responses. Indeed, some of them act as signaling molecules to target Ras pathway or protein kinases C and ultimately regulate gene expression.

Lipidomics aims at characterizing and measuring lipid molecular species as well as their interactions with partners such as lipids, proteins or other metabolites. It is a branch of the metabolomics fields, but represents a discipline per se through the structural and functional diversity of lipids compared with other metabolites or second messengers such as calcium or cGMP or cAMP.

Numerous pathological conditions are linked to impaired lipid metabolism, and lipidomics is instrumental in better understanding the molecular mechanisms, which underlie disease, and in identifying biomarkers.

Lipidomics is addressed in numerous teams at Strasbourg University. The goal of this symposium is to share major advances in lipid research and lipidomics in health and disease.



1er plan de gauche à droite : Pr Lina OBEID, Dr Pierre ANTONY, Dr Catherine TOMASETTO

2ème  plan de gauche à droite : Pr Yusuf HANNUN, Dr Nicolas VITALE, Pr Sylviane MULLER

3ème  plan de gauche à droite : Dr Dino MORAS, Dr Daniel METZGER, Pr Michel LAGARDE, Dr Florence SCHAFFNER

4ème  plan de gauche à droite : Dr Roméo RICCI, Dr Irwin DAVIDSON, Jean-Luc TOUSSAINT

5ème  plan de gauche à droite : Pierre-Alain MENDLER, Dr Christophe ROMIER, Alain LITT


Speakers :

Yusuf HANNUN (Keynote) – Stony Brook University, NY; USA

MICHEL LAGARDE – CarMeN Laboratory, IMBL, Lyon ; France
Lina OBEID (Keynote) – Stony Brook University, NY; USA
Catherine TOMASETTO – Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch; France
Nicolas VITALE – Institut des Neurosciences Cellulaires et Intégratives, Strasbourg ; France